Trial intelligence / Profile preview

Sambucol for Influenza Symptom Resolution

NCT00375115Phase 4Completed

Sponsor
Hadassah Medical Organization
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of elderberry in influenza, sponsored by Hadassah Medical Organization. Primary endpoint: Length of time to resolution of influenza illness at 10 days. Started Sep 2006; status: completed.

02

Drugs

elderberry
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00375115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00375115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call